David Hassman

Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Barbara R. Haight, Susan M. Learned, Céline M. Laffont et al. · The Lancet · 2019 · 284 citations

Nursing, Pharmacology, Pharmacotherapy +11

Repaglinide Versus Nateglinide Monotherapy

Julio Rosenstock, David Hassman, Robert D. Madder et al. · Diabetes Care · 2004 · 181 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: A randomized, double-blind, 52-week trial

W. Virgil Brown, Harold Bays, David Hassman et al. · American Heart Journal · 2002 · 159 citations

Pharmacy, Cardiology, Pharmacotherapy +11

Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain

Richard Rauck, Marvin Tark, Eva Reyes et al. · Current Medical Research and Opinion · 2009 · 136 citations

Medicine, Pharmacology, Pharmacotherapy +17

A multicenter, open-label, randomized, two-period crossovertrial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge × 6 mm needle versus a 29 gauge × 12.7 mm needle in obese patients with diabetes mellitus

Sherwyn Schwartz, David Hassman, J J Shelmet et al. · Clinical Therapeutics · 2004 · 87 citations

Medicine, Endocrinology, Diabetology +7